Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients
Not yet recruiting
- Conditions
- Amyotrophic Lateral SclerosisALS
- Registration Number
- NCT05423678
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Clinical trial participation has always been substantially skewed toward certain demographic groups. However, there has been little study on whether trial qualities impact participation in either a positive or negative way. The goal of this research is to identify the characteristics that consistently restrict patients' ability to participate in or complete a trial in which they were initially interested. This data will be analyzed via a number of demographic lenses in order to find trends that could benefit future ALS sufferers.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Lives in the United States
- Is 18+ years old
- Participant has a diagnosis of Amyotrophic Lateral Sclerosis (ALS)
- Participant has enrolled in an interventional clinical for ALS (self-reported)
Exclusion Criteria
- Inability to perform regular electronic reporting
- Patient does not understand, sign, and return consent form
- No diagnosis of Amyotrophic Lateral Sclerosis (ALS) confirmed
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of patient decides to enroll in clinical trial 3 months Rate of patients who remain in clinical trial to trial completion 12 months
- Secondary Outcome Measures
Name Time Method